International Scholarly Research Notices / 2013 / Article / Tab 2 / Review Article
Recent Developments in Liposome-Based Veterinary Therapeutics Table 2 An overview of some of the liposome-based therapeutic systems studied in recent years with clinical significance for veterinary medicine. (For explanation of symbols, please refer to legend).
Species Agent Disease/condition Reference Dogs Doxorubicin (thermosensitive liposomes) Spontaneous canine tumours [16 ]■ Cats Doxorubicin in conjunction with radiotherapy Soft-tissue sarcoma [17 ] Dogs HSA cell lysates Canine hemangiosarcoma (HSA) [23 ]▲ Dogs Endostatin DNA Soft-tissue sarcoma [24 ]▲ Chickens Salmonella fimbriae proteinsSalmonella enterica vaccine[32 ] Chickens Inactivated APEC (avian pathogenic E. coli ) Avian colibacillosis vaccine [34 ]▲ Chickens Newcastle disease virus Newcastle disease vaccine [35 ]▲ Sheep MIC3 protein from T. gondii Toxoplasma gondii vaccine[39 ]▲ Green-cheeked conures Butorphanol tartrate Experimentally induced arthritic pain [45 ] Dogs Hydromorphone Postoperative pain [46 ] Horses Diclofenac Osteoarthritis pain [48 ]
Clinical trial. ▲ Pilot study or primary evaluation in listed species.